By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


ProterixBio (Formerly Known As BioScale) 

8 St. Mary's Street, 6th Floor

Cambridge  Massachusetts  02215  U.S.A.
Phone: 617-441-5300 Fax: 617-358-2655



Start Up

Company News
ProterixBio Joins The Industrial Advisory Boards Of The COPD Foundation And The SPIROMICS Consortium 9/13/2016 11:34:37 AM
ProterixBio And The University of Zurich Receive The Michael J. Fox Foundation Grant To Develop A Novel Assay For Alpha-Synuclein Aggregates 7/28/2016 10:34:34 AM
ProterixBio Announces The Appointment Of Dr. Fernando Martinez To Its Scientific Advisory Board 7/13/2016 7:57:20 AM
BioScale, Inc. Announces Company Name Change To ProterixBio And New Focus On Pulmonary Diagnostics And Disease Management 5/3/2016 8:15:02 AM
BioScale, Inc. Launches New ViBE Software v3 For Use On ViBE Platform To Further Increase Productivity And Cost-Efficiency In Drug Development 5/26/2015 6:53:36 AM
BioScale, Inc. Launches New Acoustic Assay 6-Plate Format Cartridge For Use On Vibe™ Platform To Further Increase Productivity And Cost-Efficiency Of Protein Analyses 5/22/2014 9:24:08 AM
BioScale, Inc. Rakes in $18.8 Million Fundraise 7/10/2013 8:25:31 AM
Presentation of Collaborative Research by the National Cancer Institute, University of California, San Francisco (UCSF)-Helen Diller Comprehensive Cancer Center and BioScale, Inc. Researchers at the 2013 American Association for Cancer Research Meeting 3/5/2013 9:35:32 AM
BioScale, Inc. Presents a Comparative Analysis of in vitro and in vivo Kinase Activity and Expression Using the AMMP® Assay at the European Association of Cancer Research (EACR) Meeting 7/9/2012 9:39:41 AM
BioScale, Inc. Appoints Proteomics Leader Martin Latterich as Chief Scientific Officer 6/12/2012 10:16:10 AM